Can amniocentesis be avoided in the third generation IVF?

Preimplantation genetic testing (PGT) in third-generation IVF usually cannot replace amniocentesis, and the specific analysis is as follows:

Third-generation in vitro fertilization (IVF) involves fertilization outside the body. Before embryo transfer, cells are taken from the trophectoderm of the blastocyst for laboratory analysis, effectively screening out gene-related inherited diseases, chromosomal abnormalities, or structural chromosomal defects. Amniocentesis, on the other hand, is a form of prenatal diagnosis performed during pregnancy. It uses specialized techniques to determine whether the fetus has certain genetic or congenital disorders before birth, thus helping prevent and control such conditions. Therefore, pregnant women typically still require amniocentesis, which can help avoid fetal developmental abnormalities and reduce the risk of fetal malformations. Pregnant women are advised to undergo amniocentesis at reputable, accredited hospitals under the care of qualified physicians. Prior to the procedure, it is essential for the expectant mother to fully understand her own physiological condition and review fetal assessment data before proceeding with amniocentesis.

Women are encouraged to promptly visit a hospital for examinations to assess whether fetal development is normal. If any abnormalities are detected, timely medical consultation is recommended, along with appropriate interventions to manage the situation.